Patients with stage I non-small cell lung carcinoma at postoperative risk for local recurrence, distant metastasis, and death: Implications related to the design of clinical trials

International Journal of Radiation Oncology Biology Physics

Volumn 45, Issue 2, 1999, Pages 315-321

  Sawyer, Timothy E ^a   Bonner, James A ^a   Gould, Perry M ^a   Deschamps, Claude ^a   Lange, Carla M ^a   Li, Hongzhe ^a  

^a MAYO CLINIC   (United States)

Author keywords

Chemotherapy; Non small cell lung cancer; Radiation therapy; Stage I

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; METASTASIS; PRIORITY JOURNAL; RECURRENT DISEASE; SURVIVAL RATE;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; LYMPH NODE EXCISION; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; REGRESSION ANALYSIS; RESEARCH DESIGN; RETROSPECTIVE STUDIES; RISK; SURVIVAL RATE;

EID: 0032818807     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00189-3     Document Type: Article

References (36)

1. AJCC cancer staging manual. 5th ed. 1997;130-131 Lippincott-Raven, Philadelphia.
2. Figlin R.A., Piantodosi S. A phase 3 randomized trial of immediate combination chemotherapy vs delayed combination chemotherapy in patients with completely resected stage II and III non-small cell carcinoma of the lung. Chest. 106:(Suppl. 6):1994;310S-312S.
3. Holmes E.C., Gail M. Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma. J Clin Oncol. 4:1986;710-715.
4. Ohta M., Tsuchiya R., Shimoyama M., Sawamura K., Mori T., Miyazawa N., Suemasu K., Watanabe Y., Tomita M., Terashima M. Adjuvant chemotherapy for completely resected stage III non-small-cell lung cancer Results of a randomized prospective study . J Thorac Cardiovasc Surg. 106:1993;703-708.
5. Pisters K.M., Kris M.G., Gralla R.J., Hilaris B., McCormack P.M., Bains M.S., Martini N. Randomized trial comparing postoperative chemotherapy with vindesine and cisplatin plus thoracic irradiation with irradiation alone in stage III (N2) non-small cell lung cancer. J Surg Oncol. 56:1994;236-241.
6. Dautzenberg B., Chastang C., Arriagada R., LeChevalier T., Belpomme D., Hurdebourcq M., Lebeau B., Fabre C., Charvolin P., Guerin R.A. Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected nonsmall cell lung carcinoma A randomized trial of 267 patients . Cancer. 76:1995;779-786.
7. Feld R., Rubinstein L., Thomas P.A. Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small-cell lung cancer. J Natl Cancer Inst. 85:1993;299-306.
8. A randomized trial of postoperative adjuvant chemotherapy in non-small cell lung cancer (the second cooperative study). Eur J Surg Oncol. 21:1995;69-77.
9. Niiranen A., Niitamo-Korhonen S., Kouri M., Assendelft A., Mattson K., Pyrhonen S. Adjuvant chemotherapy after radical surgery for non-small-cell lung cancer A randomized study . J Clin Oncol. 10:1992;1927-1932.
10. Wada H., Hitomi S., Teramatsu T. Adjuvant chemotherapy after complete resection in non-small-cell lung cancer West Japan Study Group for Lung Cancer Surgery . J Clin Oncol. 14:1996;1048-1054.
11. Chemotherapy in non-small cell lung cancer A meta-analysis using updated data on individual patients from 52 randomised clinical trials . BMJ. 311:1995;899-909.
12. Van Houtte P., Rocmans P., Smets P., Goffin J.C., Lustman-Marechal J., Vanderhoeft P., Henry J. Postoperative radiation therapy in lung cancer A controlled trial after resection of curative design . Int J Radiat Oncol Biol Phys. 6:1980;983-986.
13. Lafitte J.J., Ribet M.E., Prevost B.M., Gosselin B.H., Copin M.C., Brichet A.H. Postresection irradiation for T2 N0 M0 non-small cell carcinoma A prospective, randomized study . Ann Thorac Surg. 62:1996;830-834.
14. Postoperative radiotherapy in non-small-cell lung cancer Systematic review and meta-analysis of individual patient data from nine randomised controlled trials . Lancet. 352:1998;257-263.
15. Harpole D.H. Jr, Herndon J.E. II, Young W.G. Jr, Wolfe W.G., Sabiston D.C. Jr. Stage I nonsmall cell lung cancer A multivariate analysis of treatment methods and patterns of recurrence . Cancer. 76:1995;787-796.
16. Ichinose Y., Hara N., Ohta M., Yano T., Maeda K., Asoh H., Katsuda Y. Is T factor of the TNM staging system a predominant prognostic factor in pathologic stage I non-small-cell lung cancer? A multivariate prognostic factor analysis of 151 patients. J Thorac Cardiovasc Surg. 106:1993;90-94.
17. Pairolero P.C., Williams D.E., Bergstralh E.J., Piehler J.M., Bernatz P.E., Payne W.S. Postsurgical stage I bronchogenic carcinoma Morbid implications of recurrent disease . Ann Thorac Surg. 38:1984;331-338.
18. Cangemi V., Volpino P., D'Andrea N., Puopolo M., Fabrizi S., Lonardo M.T., Piat G. Local and/or distant recurrences in T1-2/N0-1 non-small cell lung cancer. Eur J Cardiothorac Surg. 9:1995;473-478.
19. Ramacciato G., Paolini A., Volpino P., Aurello P., Balesh A.M., D'Andrea N., Del Grande E., Passaro U., Tosato F., Fegiz G. Modality of failure following resection of stage I and stage II non-small cell lung cancer. Int Surg. 80:1995;156-161.
20. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
21. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 50:1966;163-170.
22. Cox D.R. Regression models and life-tables (with discussion). J R Stat Soc (B). 34:1972;187-220.
23. Breiman L.I., Friedman J.H., Olshen R., Stone C.J. Classification and regression trees. 1984;Wadsworth International Group, Belmont, CA.
24. Parker S.L., Tong T., Bolden S., Wingo P.A. Cancer statistics, 1997. CA Cancer J Clin. 47:1997;9.
25. Mountain C.F. A new international staging system for lung cancer. Chest. 89:(Suppl. 4):1986;225S-233S.
26. Naruke T., Goya T., Tsuchiya R., Suemasu K. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg. 96:1988;440-447.
27. Sawyer T.E., Bonner J.A., Gould P.M., Garces Y.I., Foote R.L., Lange C.M., Li H. Predictors of subclinical nodal involvement in clinical stages I and II non-small cell lung cancer Implications in the inoperable and three-dimensional dose-escalation settings . Int J Radiat Oncol Biol Phys. 43:1999;965-970.
28. Deschamps C., Shaw E., Jett J., Hass C., Brooks J., Bolton J., Wiesenfeld M., Mailliard J., Jung S.H. Significance of complete versus incomplete nodal staging and sampling in stages II/IIIA non-small cell lung cancer (NSCLC) (abstract). Proc Am Soc Clin Oncol. 13:1994;353.
29. Martini N., Flehinger B.J. The role of surgery in N2 lung cancer. Surg Clin North Am. 67:1987;1037-1049.
30. Naruke T., Goya T., Tsuchiya R., Suemasu K. The importance of surgery to non-small cell carcinoma of lung with mediastinal lymph node metastasis. Ann Thorac Surg. 46:1988;603-610.
31. Izbicki J.R., Thetter O., Habekost M., Karg O., Passlick B., Kubuschok B., Busch C., Haeussinger K., Knoefel W.T., Pantel K., Schweiberer L. Radical systematic mediastinal lymphadenectomy in non-small cell lung cancer A randomized controlled trial . Br J Surg. 81:1994;229-235.
32. Izbicki J.R., Passlick B., Karg O., Bloechle C., Pantel K., Knoefel W.T., Thetter O. Impact of radical systematic mediastinal lymphadenectomy on tumor staging in lung cancer. Ann Thorac Surg. 59:1995;209-214.
33. Sawyer T.E., Bonner J.A., Gould P.J., Foote R.L., Deschamps C., Trastek V.F., Pairolero P.C., Allen M.S., Lange C.M., Li H. Identification of risk groups in patients with completely resected N1 non-small cell lung carcinoma (abstract). Int J Radiat Oncol Biol Phys. 39:(Suppl.):1997;317.
34. Matthews M.J., Kanhouwa S., Pickren J., Robinette D. Frequency of residual and metastatic tumor in patients undergoing curative surgical resection for lung cancer. Cancer Chemother Rep. 4:1973;63-67.
35. Chen Z.L., Perez S., Holmes E.C., Wang H.J., Coulson W.F., Wen D.R., Cochran A.J. Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small-cell lung carcinoma. J Natl Cancer Inst. 85:1993;493-498.
36. Passlick B., Izbicki J.R., Kubuschok B., Thetter O., Pantel K. Detection of disseminated lung cancer cells in lymph nodes Impact on staging and prognosis . Ann Thorac Surg. 61:1996;177-182.